Clinical Trials · NCT01860742
Randomized Phase III of PRRT Versus Interferon
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- Jules Bordet Institute
- Enrollment
- 0
- Start date
- Dec 2014
- Locations
- 2 sites, Belgium
- Primary endpoint
- Progression Free Survival (PFS)